{"title":"curieae乳酸菌S1L19新型乙醇脱氢酶高效生产(R)-4-氯-3-羟基丁酸乙酯","authors":"Yiping Zhang, Hualei Wang, Lifeng Chen, Kai Wu, Jingli Xie, Dongzhi Wei","doi":"10.1016/j.molcatb.2016.09.010","DOIUrl":null,"url":null,"abstract":"<div><p>Ethyl (<em>R</em>)-4-chloro-3-hydroxybutanoate ester [(<em>R</em>)-CHBE] is an important chiral intermediate for the synthesis of chiral drugs. In this study, a novel short-chain, NADH-dependent dehydrogenase (LCRIII) from <em>Lactobacillus curieae</em> S1L19 was discovered to exhibit high activity and enantioselectivity in the production of (<em>R</em>)-CHBE by reduction of ethyl 4-chloroacetoacetate (COBE). LCRIII was heterologously overexpressed in <em>Escherichia coli</em> and the protein was purified to homogeneity. Characterization of LCRIII showed broad substrate specificity towards a variety of ketones. In addition, an efficient cofactor regeneration system was constructed by co-expressing LCRIII and glucose dehydrogenase (GDH) in <em>E. coli</em> cells. Up to 1.5<!--> <!-->M (246.8<!--> <!-->g/L) COBE could be completely reduced to (<em>R</em>)-CHBE with excellent enantiomeric excess (<!--> <!-->><!--> <!-->99% <em>ee</em>) in a monophasic aqueous system. Moreover, the process could be performed even without external addition of cofactors. These results demonstrate the great potential of this process in industrial applications.</p></div>","PeriodicalId":16416,"journal":{"name":"Journal of Molecular Catalysis B-enzymatic","volume":"134 ","pages":"Pages 51-60"},"PeriodicalIF":0.0000,"publicationDate":"2016-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.molcatb.2016.09.010","citationCount":"15","resultStr":"{\"title\":\"Efficient production of ethyl (R)-4-chloro-3-hydroxybutanoate by a novel alcohol dehydrogenase from Lactobacillus curieae S1L19\",\"authors\":\"Yiping Zhang, Hualei Wang, Lifeng Chen, Kai Wu, Jingli Xie, Dongzhi Wei\",\"doi\":\"10.1016/j.molcatb.2016.09.010\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Ethyl (<em>R</em>)-4-chloro-3-hydroxybutanoate ester [(<em>R</em>)-CHBE] is an important chiral intermediate for the synthesis of chiral drugs. In this study, a novel short-chain, NADH-dependent dehydrogenase (LCRIII) from <em>Lactobacillus curieae</em> S1L19 was discovered to exhibit high activity and enantioselectivity in the production of (<em>R</em>)-CHBE by reduction of ethyl 4-chloroacetoacetate (COBE). LCRIII was heterologously overexpressed in <em>Escherichia coli</em> and the protein was purified to homogeneity. Characterization of LCRIII showed broad substrate specificity towards a variety of ketones. In addition, an efficient cofactor regeneration system was constructed by co-expressing LCRIII and glucose dehydrogenase (GDH) in <em>E. coli</em> cells. Up to 1.5<!--> <!-->M (246.8<!--> <!-->g/L) COBE could be completely reduced to (<em>R</em>)-CHBE with excellent enantiomeric excess (<!--> <!-->><!--> <!-->99% <em>ee</em>) in a monophasic aqueous system. Moreover, the process could be performed even without external addition of cofactors. These results demonstrate the great potential of this process in industrial applications.</p></div>\",\"PeriodicalId\":16416,\"journal\":{\"name\":\"Journal of Molecular Catalysis B-enzymatic\",\"volume\":\"134 \",\"pages\":\"Pages 51-60\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.molcatb.2016.09.010\",\"citationCount\":\"15\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Molecular Catalysis B-enzymatic\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1381117716301746\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Chemical Engineering\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Molecular Catalysis B-enzymatic","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1381117716301746","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Chemical Engineering","Score":null,"Total":0}
引用次数: 15
摘要
乙基(R)-4-氯-3-羟基丁酸酯[(R)-CHBE]是合成手性药物的重要手性中间体。本研究发现,curieae乳杆菌S1L19中的一种新型短链nadh依赖性脱氢酶(LCRIII)在通过还原4-氯乙酸乙酯(COBE)生产(R)-CHBE中表现出高活性和对端选择性。LCRIII蛋白在大肠杆菌中异种过表达,纯化后均质化。LCRIII对多种酮类具有广泛的底物特异性。此外,通过在大肠杆菌细胞中共表达LCRIII和葡萄糖脱氢酶(GDH),构建了高效的辅助因子再生体系。高达1.5 M (246.8 g/L)的COBE可以完全还原为(R)-CHBE,具有优异的对映体过量(>99% ee)在单相水溶液体系中。此外,该过程甚至可以在没有外部辅助因子的情况下进行。这些结果表明了该工艺在工业应用中的巨大潜力。
Efficient production of ethyl (R)-4-chloro-3-hydroxybutanoate by a novel alcohol dehydrogenase from Lactobacillus curieae S1L19
Ethyl (R)-4-chloro-3-hydroxybutanoate ester [(R)-CHBE] is an important chiral intermediate for the synthesis of chiral drugs. In this study, a novel short-chain, NADH-dependent dehydrogenase (LCRIII) from Lactobacillus curieae S1L19 was discovered to exhibit high activity and enantioselectivity in the production of (R)-CHBE by reduction of ethyl 4-chloroacetoacetate (COBE). LCRIII was heterologously overexpressed in Escherichia coli and the protein was purified to homogeneity. Characterization of LCRIII showed broad substrate specificity towards a variety of ketones. In addition, an efficient cofactor regeneration system was constructed by co-expressing LCRIII and glucose dehydrogenase (GDH) in E. coli cells. Up to 1.5 M (246.8 g/L) COBE could be completely reduced to (R)-CHBE with excellent enantiomeric excess ( > 99% ee) in a monophasic aqueous system. Moreover, the process could be performed even without external addition of cofactors. These results demonstrate the great potential of this process in industrial applications.
期刊介绍:
Journal of Molecular Catalysis B: Enzymatic is an international forum for researchers and product developers in the applications of whole-cell and cell-free enzymes as catalysts in organic synthesis. Emphasis is on mechanistic and synthetic aspects of the biocatalytic transformation.
Papers should report novel and significant advances in one or more of the following topics;
Applied and fundamental studies of enzymes used for biocatalysis;
Industrial applications of enzymatic processes, e.g. in fine chemical synthesis;
Chemo-, regio- and enantioselective transformations;
Screening for biocatalysts;
Integration of biocatalytic and chemical steps in organic syntheses;
Novel biocatalysts, e.g. enzymes from extremophiles and catalytic antibodies;
Enzyme immobilization and stabilization, particularly in non-conventional media;
Bioprocess engineering aspects, e.g. membrane bioreactors;
Improvement of catalytic performance of enzymes, e.g. by protein engineering or chemical modification;
Structural studies, including computer simulation, relating to substrate specificity and reaction selectivity;
Biomimetic studies related to enzymatic transformations.